AGE BUT NOT GENDER SELECTIVELY AFFECTS EXPRESSION OF INDIVIDUAL CYTOCHROME-P450 PROTEINS IN HUMAN LIVER

被引:118
作者
GEORGE, J [1 ]
BYTH, K [1 ]
FARRELL, GC [1 ]
机构
[1] UNIV SYDNEY,WESTMEAD HOSP,DEPT GASTROENTEROL & HEPATOL,STORR LIVER UNIT,WESTMEAD,NSW 2145,AUSTRALIA
基金
英国医学研究理事会;
关键词
CYTOCHROME P450; CYP; 3A; 2C; AGE; GENDER; MULTIVARIATE ANALYSIS;
D O I
10.1016/0006-2952(95)00192-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multivariate linear regression analysis was used to examine the influence of age, gender and environmental variables on the hepatic content of cytochromes P450 (CYP, P450) 1A2, 2C, 2E1 and 3A in 71 subjects; 21 with histologically normal livers and 50 with chronic liver disease. There was a clear negative association between age and total P450 content, NADPH-cytochrome c reductase activity and levels of 2E1 and 3A proteins. 1A2 and 2C proteins were unaltered with advancing age. Gender did not influence the expression of any of the CYP proteins. Cigarette smoking was associated with enhanced levels of 1A2, but effects of drug ingestion and alcohol consumption were not apparent in this study, probably because of case selection. It is concluded that age but not gender is a constitutional factor that influences the hepatic content of cytochrome P450 and selected CYP proteins.
引用
收藏
页码:727 / 730
页数:4
相关论文
共 26 条
  • [1] VERAPAMIL PHARMACODYNAMICS AND DISPOSITION IN YOUNG AND ELDERLY HYPERTENSIVE PATIENTS - ALTERED ELECTROCARDIOGRAPHIC AND HYPOTENSIVE RESPONSES
    ABERNETHY, DR
    SCHWARTZ, JB
    TODD, EL
    LUCHI, R
    SNOW, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) : 329 - 336
  • [2] INTERSUBJECT AND DOSE-RELATED VARIABILITY AFTER INTRAVENOUS ADMINISTRATION OF ERYTHROMYCIN
    AUSTIN, KL
    MATHER, LE
    PHILPOT, CR
    MCDONALD, PJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) : 273 - 279
  • [3] INFLUENCE OF LIVER-DISEASE AND ENVIRONMENTAL-FACTORS ON HEPATIC MONO-OXYGENASE ACTIVITY INVITRO
    BRODIE, MJ
    BOOBIS, AR
    BULPITT, CJ
    DAVIES, DS
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (01) : 39 - 46
  • [4] DUNDEE JW, 1985, ANAESTHESIA, V40, P441
  • [5] DIFFERENTIAL ALTERATIONS OF CYTOCHROME-P450 PROTEINS IN LIVERS FROM PATIENTS WITH SEVERE CHRONIC LIVER-DISEASE
    GEORGE, J
    MURRAY, M
    BYTH, K
    FARRELL, GC
    [J]. HEPATOLOGY, 1995, 21 (01) : 120 - 128
  • [6] ROLE OF HUMAN HEPATIC CYTOCHROMES-P450 IN DRUG-METABOLISM AND TOXICITY
    GEORGE, J
    FARRELL, GC
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1991, 21 (03): : 356 - 362
  • [7] GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
  • [8] PHARMACOKINETIC ASPECTS OF DRUG-THERAPY IN THE ELDERLY
    GREENBLATT, DJ
    ABERNETHY, DR
    SHADER, RI
    [J]. THERAPEUTIC DRUG MONITORING, 1986, 8 (03) : 249 - 255
  • [9] GUENGERICH FP, 1989, ANNU REV PHARMACOL, V29, P241
  • [10] EFFECT OF NORMAL AGING ON THE ACTIVITY OF HUMAN HEPATIC CYTOCHROME-P450IIE1
    HUNT, CM
    STRATER, S
    STAVE, GM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) : 1666 - 1668